As a result, the pancreatic β-cells augment their insulin secretory capacity to offset the IR resulting in the increase in plasma insulin concentration (hyperinsulinemia) such that glucose tolerance/level remains normal or only slightly impaired (1). The gene discussed is INS; the disease is Hyperinsulinemia.